Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 215, doi. 10.1007/s00262-016-1852-3
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 2
Results: 13
1
2
Using natural products to promote caspase-8-dependent cancer cell death.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 223, doi. 10.1007/s00262-016-1855-0
- By:
- Publication type:
- Article
3
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 233, doi. 10.1007/s00262-016-1882-x
- By:
- Publication type:
- Article
4
The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6-8 October 2015, Tübingen, Germany: looking back on 15 years of progress.
- Published in:
- 2017
- By:
- Publication type:
- Report
5
Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 247, doi. 10.1007/s00262-016-1891-9
- By:
- Publication type:
- Article
6
Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 141, doi. 10.1007/s00262-016-1924-4
- By:
- Publication type:
- Article
7
Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 181, doi. 10.1007/s00262-016-1928-0
- By:
- Publication type:
- Article
8
Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 161, doi. 10.1007/s00262-016-1930-6
- By:
- Publication type:
- Article
9
Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 149, doi. 10.1007/s00262-016-1932-4
- By:
- Publication type:
- Article
10
Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 171, doi. 10.1007/s00262-016-1933-3
- By:
- Publication type:
- Article
11
Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 193, doi. 10.1007/s00262-016-1934-2
- By:
- Publication type:
- Article
12
Rejection versus escape: the tumor MHC dilemma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 259, doi. 10.1007/s00262-016-1947-x
- By:
- Publication type:
- Article
13
Designing therapeutic cancer vaccines by mimicking viral infections.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 203, doi. 10.1007/s00262-016-1834-5
- By:
- Publication type:
- Article